Fusion Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript
All right. Good afternoon, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Michael Ulz, one of the biotech analysts here. And it's my pleasure to introduce the team from Fusion Pharmaceuticals, starting with John Crowley, CFO; as well as Eric Burak, Chief Technology Officer.
But before we get started today, I just need to read a quick disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please feel free to reach out to your Morgan Stanley sales rep. With that we can jump right in the Q&A.
Questions & Answers
John and Eric, thanks for joining us today. And maybe for people who aren't familiar with Fusion and more broadly, radiopharmaceuticals, if you can
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |